Fate Therapeutics, Inc. (FATE)
2.34
-0.09
(-3.70%)
USD |
NASDAQ |
Sep 24, 16:00
2.34
0.00 (0.00%)
After-Hours: 17:10
Fate Therapeutics Price : 2.34 for Sept. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 23, 2026 | 2.57 | 2.585 | 2.43 | 2.43 | 909697.0 |
| Sep 22, 2026 | 2.55 | 2.63 | 2.51 | 2.58 | 1.664M |
| Sep 21, 2026 | 2.52 | 2.575 | 2.44 | 2.53 | 1.267M |
| Sep 18, 2026 | 2.59 | 2.608 | 2.475 | 2.53 | 4.187M |
| Sep 17, 2026 | 2.48 | 2.685 | 2.46 | 2.52 | 5.137M |
| Sep 16, 2026 | 2.35 | 2.465 | 2.345 | 2.44 | 1.277M |
| Sep 15, 2026 | 2.33 | 2.40 | 2.27 | 2.35 | 828371.0 |
| Sep 14, 2026 | 2.30 | 2.40 | 2.28 | 2.34 | 645661.0 |
| Sep 11, 2026 | 2.36 | 2.39 | 2.30 | 2.31 | 742394.0 |
| Sep 10, 2026 | 2.42 | 2.45 | 2.28 | 2.33 | 751111.0 |
| Sep 09, 2026 | 2.48 | 2.52 | 2.424 | 2.44 | 553575.0 |
| Sep 08, 2026 | 2.45 | 2.55 | 2.395 | 2.50 | 1.918M |
| Sep 04, 2026 | 2.38 | 2.49 | 2.38 | 2.48 | 611433.0 |
| Sep 03, 2026 | 2.45 | 2.505 | 2.40 | 2.42 | 715438.0 |
| Sep 02, 2026 | 2.43 | 2.505 | 2.38 | 2.45 | 1.219M |
| Sep 01, 2026 | 2.35 | 2.48 | 2.335 | 2.43 | 1.041M |
| Aug 31, 2026 | 2.40 | 2.435 | 2.365 | 2.39 | 549269.0 |
| Aug 28, 2026 | 2.51 | 2.53 | 2.41 | 2.43 | 714905.0 |
| Aug 27, 2026 | 2.56 | 2.595 | 2.505 | 2.54 | 1.575M |
| Aug 26, 2026 | 2.54 | 2.60 | 2.50 | 2.57 | 1.051M |
| Aug 25, 2026 | 2.46 | 2.62 | 2.455 | 2.55 | 2.439M |
| Aug 24, 2026 | 2.34 | 2.45 | 2.23 | 2.44 | 1.311M |
| Aug 21, 2026 | 2.46 | 2.508 | 2.32 | 2.33 | 1.697M |
| Aug 20, 2026 | 2.65 | 2.65 | 2.44 | 2.45 | 1.569M |
| Aug 19, 2026 | 2.61 | 2.70 | 2.59 | 2.65 | 1.217M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 8.50 |
| Amgen, Inc. | 406.09 |
| Anika Therapeutics, Inc. | 20.28 |
| BioCryst Pharmaceuticals, Inc. | 8.515 |
| Imunon, Inc. | 1.33 |
Price Related Metrics
| PS Ratio | 43.14 |
| Price to Book Value | 1.780 |
| Earnings Yield | -45.00% |
| Market Cap | 273.06M |